Quick Answer
Citius Pharmaceuticals, Inc. reported Stockholders Equity of $67.55 million for the year ending 2025.
- Citius Pharmaceuticals, Inc. showed a decrease of -3.6% in Stockholders Equity from 2024 to 2025.
- This data is from Citius Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on December 23, 2025.
- XBRL data for this metric is available from 2010 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2011: -$26.4 thousand | Q1 2012: -$33.6 thousand | Q2 2012: -$40.5 thousand | Q3 2012: -$45.8 thousand | Q2 2013: -$61.9 thousand | Q3 2013: -$14.7 thousand | Q1 2014: -$25.1 thousand | Q2 2014: -$31.4 thousand | Q4 2014: -$823.5 thousand | Q1 2015: -$918.0 thousand | Q2 2015: -$1.18 million | Q4 2015: -$1.59 million | Q1 2016: $20.43 million | Q2 2016: $18.16 million | Q4 2016: $15.16 million | Q1 2017: $13.99 million | Q2 2017: $11.59 million | Q4 2017: $25.86 million | Q1 2018: $23.50 million | Q2 2018: $21.64 million | Q4 2018: $26.95 million | Q1 2019: $23.65 million | Q2 2019: $24.28 million | Q4 2019: $23.15 million | Q1 2020: $25.22 million | Q2 2020: $28.74 million | Q1 2021: $125.16 million | Q2 2021: $136.68 million | Q4 2021: $123.96 million | Q1 2022: $117.60 million | Q2 2022: $109.74 million | Q4 2022: $100.43 million | Q1 2023: $91.21 million | Q2 2023: $97.70 million | Q4 2023: $84.73 million | Q1 2024: $79.37 million | Q2 2024: $85.68 million | Q4 2024: $65.41 million | Q1 2025: $60.66 million | Q2 2025: $65.06 million | Q3 2025: $67.55 million | Q4 2025: $79.96 million.
- Over the full 19 years of available data (2010 to 2025), Citius Pharmaceuticals, Inc.'s Stockholders Equity has grown by 2,701,907.1%.
- Historical annual values: Fiscal year 2025: $67.55 million | Fiscal year 2024: $70.08 million | Fiscal year 2023: $90.83 million | Fiscal year 2022: $102.83 million | Fiscal year 2021: $132.18 million | Fiscal year 2020: $33.67 million | Fiscal year 2019: $27.15 million | Fiscal year 2018: $30.64 million | Fiscal year 2017: $21.95 million | Fiscal year 2016: $16.77 million | Fiscal year 2015: -$635.2 thousand | Fiscal year 2014: -$741.9 thousand | Fiscal year 2013: -$2.90 million | Fiscal year 2013: -$14.7 thousand | Fiscal year 2012: -$1.61 million | Fiscal year 2012: -$45.8 thousand | Fiscal year 2011: -$23.8 thousand | Fiscal year 2011: -$23.8 thousand | Fiscal year 2010: $2.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: